Every major financial publisher in the United States is selling an AI stock picker in the summer of 2026. All of them. The same product, repackaged seven different ways, aimed at the same retiree with the same ad budget, and when every major publisher converges on one product shape at once, the market is telling you something about demand.
Keith Kaplan at TradeSmith calls his An-E. James Altucher at Paradigm Press launched Deep Blue 2.0 on July 10, 2026. Marc Chaikin’s Power Gauge Report has been running all summer. Louis Navellier pitched Project Apex through InvestorPlace. Alexander Green at Oxford Club dropped “The NEXT Magnificent Seven” on July 18. Keith Kohl at Angel Publishing ran Quantum Quake, and Jason Bodner at Brownstone Research went live with Accelerated AI, while Joel Litman and Landon Swan co-hosted the U.S. AI Super Summit on July 10. That is eight products, eight publishers, eight gurus, and one thesis: a machine picks your stocks for you.
The thesis is real, and the marketing is something else. Walking through what the academic literature actually shows about AI stock prediction, and what these products actually claim, separates the two.
What the research says AI can do
AI can predict short-term directional stock movement with statistical significance. That is no longer controversial. The Lopez-Lira and Tang study at the University of Florida ran ChatGPT against news headlines in 2023 and produced a long-short portfolio with a Sharpe ratio above 3. The Chronos paper used a time-series foundation model, zero-shot on financial data, and hit a gross Sharpe of 3.17 over 15 years. StockGPT, a transformer trained on 50 million daily returns from 1926 to 2000, generated 16% annual alpha out-of-sample on data it had never seen. MarketSenseAI, the most ambitious framework, synthesized news, fundamentals, price data, and macro reports into buy and sell signals and held 8 to 18% alpha after transaction costs over two years on the S&P 100.
The edges exist. The catch is that they shrink fast. The Chronos gross Sharpe of 3.17 collapsed to negative after 3 basis points of trading costs per trade. The Lopez-Lira 650% return fell to 50% after 25 basis points. The StockGPT equal-weighted Sharpe of 6.5 dropped to roughly 1.0 on the value-weighted, institutionally realistic version. The market is an adversarial system. Every published anomaly gets reverse-engineered by hedge funds and traded against until the edge normalizes. The Chronos paper found this explicitly: the strongest signals were in pre-2008 data. After the financial crisis, the market got harder to predict because more capital was chasing the same signals.
The summary reads cleanly: AI works at stock prediction in the short term, the edge compresses under transaction costs and competition, and multi-source frameworks that incorporate news, fundamentals, and macro context have a wider moat than pure price-pattern models. That is the science. What the publishers are selling sits on top of the science, and the gap between the two is where the attention lives.
What the products actually claim
Each of the eight summer-2026 products takes a different angle on the same promise. Reading them as a set reveals a pattern no single promo surfaces.
Keith Kaplan / An-E / TradeSmith (November 2025, still active). Kaplan’s pitch says the Predictive Alpha AI model forecasts stock prices to the penny, up to 21 trading days ahead. The product page shows sample high-scoring picks: Applied Digital up 16% in six days, SoFi up 9% in three days, Upstart up 10% in one day, Carvana up 25% in two days. The demo is free. Type a ticker, see a projection. TradeSmith reports 57.53% directional accuracy and 60.30% target accuracy across 2,300 stocks. Those are honest numbers. They are also numbers that translate to roughly 57 calls right out of 100, which is statistically meaningful and operationally humbling. Kaplan, a software engineer turned CEO, runs the Financial Technology division at MarketWise, a publicly traded company with 2.6 million subscribers.
James Altucher / Deep Blue 2.0 / Paradigm Press (July 10, 2026 launch). Altucher’s product is a stock screening software with a patented Intel Score that claims to predict market-shaking moves before they happen. Earnings, mergers, FDA approvals. The July 10 live event was free, with an upsell to Altucher’s Investment Network at $49. Sample stocks shown included RTX. Deep Blue 2.0 is the second-generation version of a screening tool Altucher has been teasing since the original Deep Blue event earlier in the year.
Marc Chaikin / Power Gauge Report / Chaikin Analytics (ongoing, CNBC and FOX ad spend confirmed). Chaikin’s product grades every U.S. stock on a 26-factor model, producing an A-to-F rating that signals whether a stock is likely to outperform or underperform over the next three to six months. The Power Gauge itself is a real quantitative tool, and Chaikin’s indicators have been on Bloomberg terminals for decades. The summer 2026 campaign, branded 100X Starburst or Project Tengu, layers an IPO-backdoor thesis on top of the rating system. The 100X is the marketing layer. The gauge is the product.
Louis Navellier / Project Apex / InvestorPlace (active since June 2026). Navellier’s pitch ties his stock-picking system to Elon Musk’s Memphis supercomputer, xAI’s Colossus, and claims a 70X investment boom. The four picks are named in the paid report. Navellier’s system has been grading growth stocks on fundamental and quantitative factors since the 1980s. Project Apex is the current application of that system to the AI infrastructure buildout.
Alexander Green / The NEXT Magnificent Seven / Oxford Club (detected July 18, 2026). Green’s VSL pitches seven AI stocks as the next generation of trillion-dollar companies. The frame is the original Magnificent Seven, which turned $1,000 in each into roughly $1.18 million. Green claims the same math could work again in six years. Green called Nvidia at $2.75 split-adjusted in April 2013, which is verifiable in the Oxford Club Communique archive.
Keith Kohl / Quantum Quake / Angel Publishing (Stock Gumshoe solve July 13, 2026). Kohl’s pitch applies the AI lens to drug discovery, teases a $5 biotech stock, and cites milestone payments of $455 million with upside to $20 billion. The AI-drug-discovery thesis was hot in 2023, cooled, and is being re-circulated with updated catalysts. Kohl’s service is Topline Trader, a biotech catalyst trading product at $799 per year with a 90-day refund window.
Jason Bodner / Accelerated AI / Brownstone Research (Stock Gumshoe solve July 16, 2026). Bodner pitches photonics and optical networking as the replacement for copper wiring in AI data centers. The freebie pick is Broadcom, publicly named. The bonus picks live in the paid report. Bodner’s thesis is that the Magnificent Seven will be left behind by an Accelerated AI wave built on light-speed interconnects. Brownstone Research is the MarketWise imprint where Jeff Brown built his brand.
Joel Litman and Landon Swan / U.S. AI Super Summit / TradeSmith and Altimetry (July 10, 2026 event). This is a two-guru crossover. Litman runs Altimetry, which grades stocks on Uniform Accounting, a framework that strips out GAAP elections to reveal what he calls invisible fundamentals. Swan co-founded Chaikin’s Power Gauge before launching his own work. The Super Summit pitched five small-cap energy stocks tied to the AI power bottleneck. Litman’s institutional clients include all ten of the world’s largest money managers, paying up to $100,000 per month according to Altimetry’s corporate profile.
The pattern underneath
Reading the eight together, three things become visible that no single promo surfaces.
First, the AI stock picker is now a product category, not a niche. Eight publishers, two publisher families (Agora and MarketWise), independents (Angel, Brownstone, Oxford Club, Chaikin Analytics). When every major publisher converges on one product shape at once, the market is telling you something about demand. Retirees want a machine to do the picking, and the publishers are supplying the machine.
Second, the claims vary wildly in specificity. Kaplan publishes directional accuracy numbers (57.53%), Chaikin’s gauge is a decades-old quantitative tool on Bloomberg terminals, Altucher’s Intel Score is patented, and Litman’s Uniform Accounting is an institutional framework with verifiable clients. At the other end, Green’s seven stocks and Kohl’s biotech pick and Bodner’s photonics names come with percentage gain projections but no audited track record, because no newsletter track record in the industry is independently audited. That is the publisher’s exclusion at work. The grading runs from genuinely quantitative tools with published methodology to category-error narratives with picks attached.
Third, the structural gap between the academic edge and the marketed product is where the reader’s attention should live. The research says AI can predict short-term direction with statistical significance, that the edge compresses under costs, and that multi-source frameworks outperform pure price-pattern models. The products say AI can pick stocks to the penny, hit 100X returns, and make you a millionaire in six years. Both can be true in a narrow technical sense. The products are not lying about AI. They are taking the real finding, stripping out the qualifications, and projecting the ceiling.
The 1990s parallel
This has happened before. In the late 1990s, every financial publisher sold a stock-picking system. The Motley Fool ran its Foolish Four mechanical screen. Louis Navellier’s MPT Review was a quantitative grading service. Value Line had been ranking stocks on a numerical system since the 1960s. Zachs ran a rank model. Investor’s Business Daily built the Relative Strength rating. The pitch was the same one you hear now: a systematic, rule-based approach beats human discretion, and you can subscribe to the output.
The 1990s version had real edges too. Value Line’s Timeliness Ranking System produced documented excess returns in academic studies through the 1980s. The catch was the same one the AI literature surfaces now: the edges decayed. The Value Line anomaly shrank as the study became famous and capital piled in. The mechanical screens worked in backtests and underperformed in live trading after costs and after the screens got crowded. The category survived because the publishers kept finding new screens, new factors, and new framings. The product category did not die. It iterated.
The 2026 AI stock picker wave is the same product with a new engine. The 1990s version ran on factor models and historical rankings. The 2026 version runs on transformers and ensemble learning. The marketing structure is identical: a real edge from the research literature, compressed into a paid product, sold to the same audience with the same promise that the machine can do what the human cannot.
The lesson from the 1990s is not that the products failed. Many of them worked, for a while, for some subscribers, with the right sizing. The lesson is that the category persisted by cycling. Every cycle produced a new generation of systems. The systems that survived were the ones that acknowledged the edge was fragile and iterated around it. The ones that claimed the edge was permanent and the picks were certain are the ones the complaint boards remember.
Where this leaves you
The academic edge is real and compresses. The marketed product takes the edge, removes the qualifications, and prices the result. A retiree reading one of these eight pitches is choosing which layer to buy into.
The quantitative tools with published methodology, audited institutional track records, and honest accuracy numbers sit closer to the research. Kaplan’s 57.53% directional accuracy is a real number, and TradeSmith publishes it because they know the number is defensible, while Chaikin’s Power Gauge is a real tool that institutions pay for and Litman’s Uniform Accounting is a real framework with real clients.
The picks-and-shovels narratives that name a stock, project a multiple, and attach a countdown timer take the AI framing as atmosphere and sell a ticker, with the AI as the wrapper and the pick as the product. Green’s seven stocks, Kohl’s biotech pick, Bodner’s photonics names, Navellier’s Project Apex picks: these are stock recommendations layered on top of an AI theme, with internal, unaudited methodology.
The summer 2026 convergence tells you something about the category. The same publishers who sold mechanical screens in 1998, gold stock picks in 2011, crypto picks in 2017, and SPAC picks in 2021 are now selling AI stock pickers. The product category is durable, the individual products cycle, and the research underneath is real while the edges compress and the marketing always pushes past both. What separates the eight offerings is the distance between the published methodology and the marketed ceiling — and that distance is the part the reader can measure before buying anything. For the wider frame on whether AI stocks are a bubble or a supercycle, the two-camps analysis separates the bear and bull cases.